2-butyl-3-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one, 95%, 10g

5-Chloro-2-hydroxybenzophenone>98.0%(GC)25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid, 97%, 5g

METHYL 4-CYANO-3-HYDROXYBENZOATE, 95.0%, 250mg

4,6-Dichloro-5-iodo-2-methylpyrimidine, 97.0%, 250mg

2H-Chromene-3-carboxylic acid, 95.0%, 5g

N-(4-Chloro-3-fluorophenyl)-2,2,2-trifluoroacetamide, 97%, 100mg

Methyl 5-Bromo-2-chloronicotinate, 97.0%, 100g

Methyl 3,4-dihydro-2H-1,4-benzoxazine-7-carboxylate, 95.0%, 1g

1-(Benzyloxy)-3-fluoro-5-nitrobenzene, 97%, 250mg

Hose VERSILON 2001, 6.4 mm, 9.5 mm, 15 m

4,4,5,5-Tetramethyl-2-(naphthalen-1-ylmethyl)-1,3,2-dioxaborolane, 98%, 1g

6-(2-(Quinolin-2-yl)propan-2-yl)pyridin-2(1H)-one, 98%, 100mg